Raymond James Financial Inc. bought a new stake in Amdocs Limited (NASDAQ:DOX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 522,600 shares of the technology company's stock, valued at approximately $44,494,000. Raymond James Financial Inc. owned about 0.46% of Amdocs as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Private Trust Co. NA grew its holdings in shares of Amdocs by 62.9% during the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after purchasing an additional 117 shares during the last quarter. Brooklyn Investment Group bought a new stake in shares of Amdocs during the third quarter worth about $28,000. Jones Financial Companies Lllp bought a new stake in shares of Amdocs during the fourth quarter worth about $36,000. SBI Securities Co. Ltd. bought a new stake in shares of Amdocs during the fourth quarter worth about $41,000. Finally, Global Retirement Partners LLC grew its holdings in shares of Amdocs by 45.6% during the fourth quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock worth $48,000 after purchasing an additional 175 shares during the last quarter. Institutional investors own 92.02% of the company's stock.
Amdocs Price Performance
Shares of DOX opened at $88.79 on Wednesday. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $93.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The business's 50 day moving average price is $86.54 and its two-hundred day moving average price is $87.03. The firm has a market cap of $10.02 billion, a PE ratio of 20.60, a price-to-earnings-growth ratio of 1.47 and a beta of 0.68.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. On average, equities analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be paid a $0.527 dividend. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs's previous quarterly dividend of $0.48. This represents a $2.11 annualized dividend and a yield of 2.37%. Amdocs's payout ratio is 48.72%.
Analyst Ratings Changes
A number of equities analysts recently commented on DOX shares. Oppenheimer lifted their price objective on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 13th. StockNews.com lowered Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th. Finally, Barclays cut their price objective on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $101.20.
Check Out Our Latest Stock Report on Amdocs
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
